CHI3L1 and in situ carcinoma: CHI3L1, also named YKL-40, is a molecule released by activated macrophages and astrocytes, and it was proposed as a putative CSF biomarker of disease activity, indicating higher risk of conversion from CIS to MS (Comabella et al., 2010).